Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals.

Falsey AR, Walsh EE, Capellan J, Gravenstein S, Zambon M, Yau E, Gorse GJ, Edelman R, Hayden FG, McElhaney JE, Neuzil KM, Nichol KL, Simões EA, Wright PF, Sales VM.

J Infect Dis. 2008 Nov 1;198(9):1317-26. doi: 10.1086/592168.

PMID:
18855558
[PubMed - indexed for MEDLINE]
Free Article
2.

Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials.

Lee MS, Walker RE, Mendelman PM.

Hum Vaccin. 2005 Jan-Feb;1(1):6-11. Epub 2005 Jan 10. Review.

PMID:
17038832
[PubMed - indexed for MEDLINE]
Free Article
3.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
[PubMed - indexed for MEDLINE]
4.

Respiratory syncytial virus (RSV) vaccines--two steps back for one leap forward.

Power UF.

J Clin Virol. 2008 Jan;41(1):38-44. Review.

PMID:
18340669
[PubMed - indexed for MEDLINE]
5.

Clinical experience with respiratory syncytial virus vaccines.

Piedra PA.

Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S94-9. Review.

PMID:
12671459
[PubMed - indexed for MEDLINE]
6.

Immunization against viral respiratory disease: a review.

Greenberg HB, Piedra PA.

Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S254-61. Review.

PMID:
15577581
[PubMed - indexed for MEDLINE]
7.

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus.

Takimoto T, Hurwitz JL, Zhan X, Krishnamurthy S, Prouser C, Brown B, Coleclough C, Boyd K, Scroggs RA, Portner A, Slobod KS.

Viral Immunol. 2005;18(2):255-66. Review.

PMID:
16035938
[PubMed - indexed for MEDLINE]
8.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
[PubMed - indexed for MEDLINE]
9.

Respiratory syncytial virus infection in adults.

Falsey AR.

Semin Respir Crit Care Med. 2007 Apr;28(2):171-81. Review.

PMID:
17458771
[PubMed - indexed for MEDLINE]
10.

Respiratory syncytial virus vaccines for otitis media.

Anderson LJ.

Vaccine. 2000 Dec 8;19 Suppl 1:S59-65. Review.

PMID:
11163465
[PubMed - indexed for MEDLINE]
11.

Respiratory syncytial virus infection in elderly adults.

Falsey AR, Walsh EE.

Drugs Aging. 2005;22(7):577-87. Review.

PMID:
16038573
[PubMed - indexed for MEDLINE]
12.

Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development.

Brandenburg AH, Neijens HJ, Osterhaus AD.

Vaccine. 2001 Apr 6;19(20-22):2769-82. Review.

PMID:
11282187
[PubMed - indexed for MEDLINE]
13.

Challenges in developing a pediatric RSV vaccine.

Schickli JH, Dubovsky F, Tang RS.

Hum Vaccin. 2009 Sep;5(9):582-91. Epub 2009 Sep 28. Review.

PMID:
19556888
[PubMed - indexed for MEDLINE]
Free Article
14.

Prevention strategies for respiratory syncytial virus: passive and active immunization.

Englund JA.

J Pediatr. 1999 Aug;135(2 Pt 2):38-44. Review.

PMID:
10431138
[PubMed - indexed for MEDLINE]
15.

Carriers for the delivery of a vaccine against respiratory syncytial virus.

Cranage M, Taylor G.

Expert Opin Biol Ther. 2005 Jul;5(7):939-52. Review.

PMID:
16018739
[PubMed - indexed for MEDLINE]
16.

Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.

Beeler JA, Eichelberger MC.

Microb Pathog. 2013 Feb;55:9-15. doi: 10.1016/j.micpath.2012.11.013. Epub 2012 Dec 13. Review.

PMID:
23247146
[PubMed - indexed for MEDLINE]
17.

Respiratory syncytial virus infection in older persons.

Falsey AR.

Vaccine. 1998 Nov;16(18):1775-8. Review.

PMID:
9778756
[PubMed - indexed for MEDLINE]
18.

The non-structural proteins of RSV: targeting interferon antagonists for vaccine development.

Teng MN.

Infect Disord Drug Targets. 2012 Apr;12(2):129-37. Review.

PMID:
22335499
[PubMed - indexed for MEDLINE]
19.

Human and bovine respiratory syncytial virus vaccine research and development.

Meyer G, Deplanche M, Schelcher F.

Comp Immunol Microbiol Infect Dis. 2008 Mar;31(2-3):191-225. Epub 2007 Aug 27. Review.

PMID:
17720245
[PubMed - indexed for MEDLINE]
20.

Respiratory syncytial virus vaccine development.

Murata Y.

Clin Lab Med. 2009 Dec;29(4):725-39. doi: 10.1016/j.cll.2009.07.004. Review.

PMID:
19892231
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk